{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:42:22Z","timestamp":1791859342410,"version":"4.3.4"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.biopha.2017.05.095","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T14:31:24Z","timestamp":1496241084000},"page":"501-508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["A holistic review on the autoimmune disease vitiligo with emphasis on the causal factors"],"prefix":"10.1016","volume":"92","author":[{"given":"Seema","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswa Ranjan","family":"Meher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Shams ul","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.05.095_bib0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2017.05.095_bib0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/0019-5154.57604","article-title":"Vitiligo and the melanocyte reservoir","volume":"54","author":"Falabella","year":"2009","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/0019-5154.39745","article-title":"Vitiligo: is it just a dermatological disorder?","volume":"53","author":"Pandve","year":"2008","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0020","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4103\/0019-5154.103067","article-title":"Childhood vitiligo: treatment paradigms","volume":"57","author":"Kanwar","year":"2012","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00926230600998482","article-title":"The problems in sexual functions of vitiligo and chronic urticaria patients","volume":"33","author":"Sukan","year":"2007","journal-title":"J. Sex Marital Ther."},{"key":"10.1016\/j.biopha.2017.05.095_bib0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40272-015-0135-3","article-title":"Current management of pediatric vitiligo","volume":"17","author":"Van Driessche","year":"2015","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.biopha.2017.05.095_bib0035","first-page":"250","article-title":"A clinical study of the spectrum of vitiligo in children versus adults and its associations","volume":"4","author":"Prakash","year":"2013","journal-title":"Online J."},{"key":"10.1016\/j.biopha.2017.05.095_bib0040","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1016\/j.ddmec.2008.02.001","article-title":"Modifying skin pigmentation \u2013 approaches through intrinsic biochemistry and exogenous agents","volume":"5","author":"Brenner","year":"2008","journal-title":"Drug Discov. Today. Dis. Mech."},{"key":"10.1016\/j.biopha.2017.05.095_bib0045","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Vitiligo global issue consensus conference panelists, revised classification\/nomenclature of vitiligo and related issues: the vitiligo global issues consensus conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.biopha.2017.05.095_bib0050","article-title":"Vitiligo","volume":"2008","author":"Matin","year":"2008","journal-title":"BMJ Clin. Evid."},{"key":"10.1016\/j.biopha.2017.05.095_bib0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/138920010791526105","article-title":"Vitiligo: pathogenetic hypotheses and targets for current therapies","volume":"11","author":"Guerra","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2017.05.095_bib0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jgg.2011.05.005","article-title":"Recent progress in the genetics of generalized vitiligo","volume":"38","author":"Spritz","year":"2011","journal-title":"J. Genet. Genomics"},{"key":"10.1016\/j.biopha.2017.05.095_bib0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5021\/ad.2014.26.1.61","article-title":"Clinical course of segmental vitiligo: a retrospective study of eighty-seven patients","volume":"26","author":"Park","year":"2014","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/09546634.2012.762638","article-title":"Vitiligo management strategy in Jeddah, Saudi Arabia as reported by dermatologists and experienced by patients","volume":"25","author":"Ismail","year":"2014","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.biopha.2017.05.095_bib0075","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/dth.12363","article-title":"Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB","volume":"29","author":"Stanimirovic","year":"2016","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.biopha.2017.05.095_bib0080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4103\/0019-5154.103067","article-title":"Childhood vitiligo: treatment paradigms","volume":"57","author":"Kanwar","year":"2012","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2230.2009.03412.x","article-title":"Depigmentation therapy in vitiligo universalis with cryotherapy and 4-hydroxyanisole","volume":"35","author":"Di Nuzzo","year":"2010","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0090","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1346-8138.2010.01139.x","article-title":"Vitiligo: a review of the published work","volume":"38","author":"Yaghoobi","year":"2011","journal-title":"J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0095","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4103\/0019-5154.117323","article-title":"Epidermotropic metastatic melanoma with perilesional depigmentation in an Indian male","volume":"58","author":"Doshi","year":"2013","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0100","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/ijd.12055","article-title":"A study of clinical profiles of vitiligo in different ages: an analysis of 669 outpatients","volume":"53","author":"de Barros","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0105","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1089\/thy.2010.1643","article-title":"Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease","volume":"20","author":"Spritz","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.biopha.2017.05.095_bib0110","first-page":"167","article-title":"Update on the genetics characterization of vitiligo","volume":"5","author":"Al-Shobaili","year":"2011","journal-title":"Int. J. Health Sci. (Qassim)"},{"issue":"3","key":"10.1016\/j.biopha.2017.05.095_bib0115","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/jid.2009.403","article-title":"Multiple genes and locus interactions in susceptibility to vitiligo","volume":"130","author":"Smith","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2017.05.095_bib0120","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/jid.2009.273","article-title":"Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1)","volume":"130","author":"Jin Y1","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0125","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/BF03345516","article-title":"Autoimmune regulator (AIRE) gene on chromosome 21: Implications for autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and more common manifestations of endocrine autoimmunity","volume":"25","author":"Meyer","year":"2002","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.biopha.2017.05.095_bib0130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/schbul\/sbm019","article-title":"Is COMT a susceptibility gene for schizophrenia?","volume":"33","author":"Williams","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.biopha.2017.05.095_bib0135","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00403-008-0900-z","article-title":"The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients","volume":"301","author":"Zhang","year":"2009","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.biopha.2017.05.095_bib0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.biopha.2017.05.095_bib0145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-0749.2005.00242.x","article-title":"Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo","volume":"18","author":"Laberge","year":"2005","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.biopha.2017.05.095_bib0150","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/324470","article-title":"Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus","volume":"69","author":"Nath","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biopha.2017.05.095_bib0155","first-page":"200","article-title":"Vitiligo and autoantibodies of celiac disease","volume":"4","author":"Shahmoradi","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.biopha.2017.05.095_bib0160","first-page":"255","article-title":"Vitiligo disease triggers: psychological stressors preceding the onset of disease","volume":"95","author":"Silverberg","year":"2015","journal-title":"Cutis"},{"key":"10.1016\/j.biopha.2017.05.095_bib0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.09.003","article-title":"Vitiligo: how do oxidative stress-induced autoantigens trigger autoimmunity?","volume":"81","author":"Xie","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.biopha.2017.05.095_bib0170","first-page":"57","article-title":"Topical treatment and combination approaches for vitiligo: new insights, new developments","volume":"145","author":"Hossani-Madani","year":"2010","journal-title":"G. Ital. Di Dermatologia E Venereol. Organo Uff. Soc. Ital. Di Dermatologia E Sifilogr."},{"key":"10.1016\/j.biopha.2017.05.095_bib0175","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/0019-5154.139872","article-title":"Topical steroid-damaged skin","volume":"59","author":"Abraham","year":"2014","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0180","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4103\/2229-5178.142483","article-title":"Side-effects of topical steroids: a long overdue revisit","volume":"5","author":"Coondoo","year":"2014","journal-title":"Indian Dermatol. Online J."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2017.05.095_bib0185","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1529-8019.2008.00198.x","article-title":"Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects","volume":"21","author":"Lotti","year":"2008","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.biopha.2017.05.095_bib0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/0019-5154.113944","article-title":"Phototherapy in vitiligo: assessing the compliance, response and patient\u2019s perception about disease and treatment","volume":"58","author":"Kandaswamy","year":"2013","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0195","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-4632.2012.05697.x","article-title":"Efficacy of topical calcineurin inhibitors in vitiligo","volume":"52","author":"Wong","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0200","series-title":"Drug Class Review: Topical Calcineurin Inhibitors","author":"Lee","year":"2017"},{"key":"10.1016\/j.biopha.2017.05.095_bib0205","doi-asserted-by":"crossref","first-page":"e3173","DOI":"10.1097\/MD.0000000000003173","article-title":"Calcineurin inhibitors associated posterior reversible encephalopathy syndrome in solid organ transplantation: report of 2 cases and literature review","volume":"95","author":"Song","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.biopha.2017.05.095_bib0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/0019-5154.70663","article-title":"Cosmetic camouflage in vitiligo","volume":"55","author":"Sarveswari","year":"2010","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0215","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-4632.2008.03356.x","article-title":"Dihydroxyacetone: a safe camouflaging option in vitiligo","volume":"47","author":"Rajatanavin","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0220","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.mrgentox.2004.03.002","article-title":"Dihydroxyacetone, the active browning ingredient in sunless tanning lotions, induces DNA damage, cell-cycle block and apoptosis in cultured HaCaT keratinocytes","volume":"560","author":"Petersen","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.biopha.2017.05.095_bib0225","first-page":"384","article-title":"Camouflaging agents for vitiligo patients","volume":"15","author":"Hossain","year":"2016","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0230","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.bjps.2009.03.013","article-title":"Micropigmentation: tattooing for the treatment of lip vitiligo","volume":"63","author":"Singh","year":"2010","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"10.1016\/j.biopha.2017.05.095_bib0235","first-page":"685","article-title":"Vitiligo surgical, laser, and alternative therapies: a review and case series","volume":"12","author":"Wassef","year":"2013","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0240","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/09546630601028711","article-title":"Topical pimecrolimus: a new horizon for vitiligo treatment?","volume":"17","author":"Sendur","year":"2006","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.biopha.2017.05.095_bib0245","first-page":"36","article-title":"Successful treatment of extensive vitiligo with monobenzone","volume":"5","author":"Rordam","year":"2012","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0250","first-page":"21","article-title":"Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial., BMC Complement","volume":"11","author":"Szczurko","year":"2011","journal-title":"Altern. Med."},{"key":"10.1016\/j.biopha.2017.05.095_bib0255","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jep.2015.03.080","article-title":"Pre-clinical evidences of Pyrostegia venusta in the treatment of vitiligo","volume":"168","author":"Moreira","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0260","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40257-015-0153-5","article-title":"Alternative systemic treatments for vitiligo: a review","volume":"16","author":"Cohen","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0265","first-page":"13","article-title":"Polypodium leucotomos as an adjunct treatment of pigmentary disorders","volume":"7","author":"Nestor","year":"2014","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0270","first-page":"333","article-title":"Khellin, a naturally occurring furochromone, used for the photochemotherapy of skin diseases: mechanism of action","volume":"43","author":"Vedaldi","year":"1988","journal-title":"Farmaco. Sci."},{"key":"10.1016\/j.biopha.2017.05.095_bib0275","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1529-8019.2009.01252.x","article-title":"Monochromatic excimer light 308\u00f2nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study","volume":"22","author":"Saraceno","year":"2009","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.biopha.2017.05.095_bib0280","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4103\/0019-5154.87116","article-title":"Hypothesis: zinc can be effective in treatment of vitiligo","volume":"56","author":"Bagherani","year":"2011","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0285","first-page":"127","article-title":"Oral and topical L-phenylalanine, clobetasol propionate, and UVA\/sunlight\u2013a new study for the treatment of vitiligo","volume":"1","author":"Camacho","year":"2002","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/039463201202500101","article-title":"Neuro-immuno-endocrine processes in vitiligo pathogenesis","volume":"25","author":"Miniati","year":"2012","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0295","first-page":"1265","article-title":"Lysosome-related organelles","volume":"14","author":"Dell\u2019Angelica","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2017.05.095_bib0300","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.3390\/ijms10094066","article-title":"Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration","volume":"10","author":"Ebanks","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2017.05.095_bib0305","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5114\/pdia.2013.33376","article-title":"Skin melanocytes: biology and development","volume":"30","author":"Cichorek","year":"2013","journal-title":"Post\u0229py Dermatologii I Alergol"},{"key":"10.1016\/j.biopha.2017.05.095_bib0310","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/exd.12621","article-title":"Cytosolic dsDNA triggers apoptosis and pro-inflammatory cytokine production in normal human melanocytes","volume":"24","author":"Wang","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0315","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","article-title":"Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo","volume":"192","author":"Yee","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2017.05.095_bib0320","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5114\/pdia.2014.43497","article-title":"Current aspects of vitiligo genetics","volume":"31","author":"Czajkowski","year":"2014","journal-title":"Post\u0229py Dermatologii I Alergol"},{"key":"10.1016\/j.biopha.2017.05.095_bib0325","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1468-3083.2012.04501.x","article-title":"Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo","volume":"27","author":"Kroon","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0330","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1096\/fj.12-226779","article-title":"Basic evidence for epidermal H2O2\/ONOO?mediated oxidation\/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS","volume":"27","author":"Schallreuter","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2017.05.095_bib0335","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1073\/pnas.0602210103","article-title":"Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process","volume":"103","author":"Donelan","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2017.05.095_bib0340","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.biopha.2017.05.095_bib0345","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.yhbeh.2006.06.019","article-title":"Role of corticotropin releasing factor in anxiety disorders: a translational research perspective","volume":"50","author":"Risbrough","year":"2006","journal-title":"Horm. Behav."},{"key":"10.1016\/j.biopha.2017.05.095_bib0350","doi-asserted-by":"crossref","first-page":"T135","DOI":"10.1530\/JME-15-0257","article-title":"60 years of POMC: adrenal and extra-adrenal functions of ACTH","volume":"56","author":"Gallo-Payet","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0355","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1096\/fj.06-7398com","article-title":"Proopiomelanocortin (POMC), the ACTH\/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis","volume":"21","author":"Rousseau","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2017.05.095_bib0360","doi-asserted-by":"crossref","first-page":"14579","DOI":"10.1038\/srep14579","article-title":"Melanin production through novel processing of proopiomelanocortin in the extracellular compartment of the auricular skin of C57BL\/6 mice after UV-irradiation","volume":"5","author":"Yamamoto","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2017.05.095_bib0365","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.biopha.2017.05.095_bib0370","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3121\/cmr.2007.738","article-title":"Celiac disease and autoimmune thyroid disease","volume":"5","author":"Ch\u2019ng","year":"2007","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.biopha.2017.05.095_bib0375","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4103\/0019-5154.96227","article-title":"A study on cutaneous manifestations of thyroid disease","volume":"57","author":"Puri","year":"2012","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0380","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/nar\/27.1.229","article-title":"SMART: identification and annotation of domains from signalling and extracellular protein sequences","volume":"27","author":"Ponting","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2017.05.095_bib0385","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.RES.77.4.856","article-title":"The mechanically active domain of titin in cardiac muscle","volume":"77","author":"Trombit\u00e1s","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2017.05.095_bib0390","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1111\/j.1432-1033.2004.04429.x","article-title":"Regulation of the actin-myosin interaction by titin","volume":"271","author":"Niederl\u00e4nder","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.biopha.2017.05.095_bib0395","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1590\/S0066-782X2011005000023","article-title":"The role of titin in the modulation of cardiac function and its pathophysiological implications","volume":"96","author":"Castro-Ferreira","year":"2011","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0400","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1134\/S0006297912130093","article-title":"New titin (connectin) isoforms and their functional role in striated muscles of mammals: facts and suppositions","volume":"77","author":"Vikhlyantsev","year":"2012","journal-title":"Biochem. Biokhimiia."},{"key":"10.1016\/j.biopha.2017.05.095_bib0405","first-page":"13","article-title":"Iodine, Iodine metabolism and Iodine deficiency disorders revisited","volume":"14","author":"Ahad","year":"2010","journal-title":"Metab"},{"key":"10.1016\/j.biopha.2017.05.095_bib0410","unstructured":"G.S. Artanta\u015f S, G\u00fcl U, Kili\u00e7 A, Skin findings in thyroid diseases, (n.d.)."},{"key":"10.1016\/j.biopha.2017.05.095_bib0415","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1687-9856-2011-18","article-title":"Incidence of vitiligo in children with Graves\u2019 disease and Hashimoto\u2019s thyroiditis","volume":"2011","author":"Prindaville","year":"2011","journal-title":"Int. J. Pediatr. Endocrinol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0420","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4158\/EP11205.OR","article-title":"Autoimmune thyroid disease in patients with vitiligo: prevalence study in India","volume":"18","author":"Kumar","year":"2012","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.biopha.2017.05.095_bib0425","doi-asserted-by":"crossref","first-page":"725410","DOI":"10.1155\/2013\/725410","article-title":"Tyrosine kinase inhibitors induced thyroid dysfunction: a review of its incidence, pathophysiology, clinical relevance, and treatment","volume":"2013","author":"Ahmadieh","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.biopha.2017.05.095_bib0430","doi-asserted-by":"crossref","first-page":"a005991","DOI":"10.1101\/cshperspect.a005991","article-title":"Signaling by sensory receptors","volume":"4","author":"Julius","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0435","series-title":"Signaling Through G-Protein-Linked Cell-Surface Receptors","author":"Alberts","year":"2002"},{"key":"10.1016\/j.biopha.2017.05.095_bib0440","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.det.2007.06.005","article-title":"Melanocyte receptors: clinical implications and therapeutic relevance","volume":"25","author":"Carlson","year":"2007","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.biopha.2017.05.095_bib0445","first-page":"361","article-title":"Thyroid disorders","author":"Gessl","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0450","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/2229-516X.96795","article-title":"Prevalence of hypothyroidism in infertile women and evaluation of response of treatment for hypothyroidism on infertility","volume":"2","author":"Verma","year":"2012","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"10.1016\/j.biopha.2017.05.095_bib0455","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5021\/ad.2010.22.4.373","article-title":"What should be considered in treatment of melasma","volume":"22","author":"Kang","year":"2010","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0460","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.15104","article-title":"Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors","volume":"5","author":"Natale","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2017.05.095_bib0465","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4103\/0110-5558.72420","article-title":"Male hypogonadism: symptoms and treatment","volume":"1","author":"Kumar","year":"2010","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.biopha.2017.05.095_bib0470","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1055\/s-0029-1225629","article-title":"Effect of testosterone on thyroid weight and function in iodine deficient castrated rats","volume":"41","author":"Bahrami","year":"2009","journal-title":"Horm. Metab. Res.=Horm. Und Stoffwechselforsch.=Horm. M\u00e9tabolisme"},{"key":"10.1016\/j.biopha.2017.05.095_bib0475","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1902\/jop.2016.150541","article-title":"Effects of melatonin on oxidative stress index and alveolar bone loss in diabetic rats with periodontitis","volume":"87","author":"Kose","year":"2016","journal-title":"J. Periodontol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0480","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tem.2007.10.007","article-title":"Melatonin in the skin: synthesis, metabolism and functions","volume":"19","author":"Slominski","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2017.05.095_bib0485","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1600-0625.2008.00767.x","article-title":"Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair","volume":"17","author":"Fischer","year":"2008","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0490","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mce.2012.01.004","article-title":"Melatonin membrane receptors in peripheral tissues: distribution and functions","volume":"351","author":"Slominski","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0495","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0378-6323.48654","article-title":"Vitiligo and diet: a theoretical molecular approach with practical implications","volume":"75","author":"Namazi","year":"2009","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0500","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000370303","article-title":"Rapid partial repigmentation of vitiligo in a young female adult with a gluten-free diet","volume":"6","author":"Khandalavala","year":"2014","journal-title":"Case Rep. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0505","series-title":"Chapter 2 Thyroid Hormone Synthesis And Secretion","author":"Miot","year":"2017"},{"key":"10.1016\/j.biopha.2017.05.095_bib0510","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/0019-5545.42391","article-title":"Understanding nutrition, depression and mental illnesses","volume":"50","author":"Rao","year":"2008","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.biopha.2017.05.095_bib0515","first-page":"1413","article-title":"L-tyrosine improves neuroendocrine function in a mouse model of chronic stress","volume":"7","author":"Wang","year":"2012","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2017.05.095_bib0520","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1755-148X.2011.00898.x","article-title":"L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions","volume":"25","author":"Slominski","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.biopha.2017.05.095_bib0525","doi-asserted-by":"crossref","DOI":"10.1093\/jn\/137.6.1539S","article-title":"Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain","volume":"137","author":"Fernstrom","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2017.05.095_bib0530","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/bies.200900167","article-title":"The biological significance of substrate inhibition: a mechanism with diverse functions","volume":"32","author":"Reed","year":"2010","journal-title":"Bioessays"},{"key":"10.1016\/j.biopha.2017.05.095_bib0535","series-title":"The Central Role of Enzymes as Biological Catalysts","author":"Cooper","year":"2000"},{"key":"10.1016\/j.biopha.2017.05.095_bib0540","doi-asserted-by":"crossref","first-page":"31517","DOI":"10.1074\/jbc.M704032200","article-title":"A novel mechanism for substrate inhibition in mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase","volume":"282","author":"Burton","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.05.095_bib0545","doi-asserted-by":"crossref","first-page":"10446","DOI":"10.1074\/jbc.M109.094383","article-title":"Structural basis for L-lysine feedback inhibition of homocitrate synthase","volume":"285","author":"Bulfer","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.05.095_bib0550","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jaad.2007.08.049","article-title":"Milk consumption and acne in teenaged boys","volume":"58","author":"Adebamowo","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0555","first-page":"5","article-title":"Alcohol and skin disorders: with a focus on psoriasis","volume":"16","author":"Kazakevich","year":"2011","journal-title":"Skin Therapy Lett."},{"key":"10.1016\/j.biopha.2017.05.095_bib0560","first-page":"13","article-title":"The epidemiology of acne vulgaris in late adolescence","volume":"7","author":"Lynn","year":"2016","journal-title":"Adolesc. Health. Med. Ther."},{"key":"10.1016\/j.biopha.2017.05.095_bib0565","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/derm.2.1.12016","article-title":"Fundamental questions to sun protection: a continuous education symposium on vitamin D, immune system and sun protection at the University of Z\u00fcrich","volume":"2","author":"Schlumpf","year":"2010","journal-title":"Dermatoendocrinology"},{"key":"10.1016\/j.biopha.2017.05.095_bib0570","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1745-6673-3-26","article-title":"Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity","volume":"3","author":"Lachenmeier","year":"2008","journal-title":"J. Occup. Med. Toxicol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0575","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1258\/shorts.2011.011034","article-title":"Alcohol hand abuse: a cross-sectional survey of skin complaints and usage patterns at a large UK teaching hospital","volume":"2","author":"McKenzie","year":"2011","journal-title":"JRSM Short Rep."},{"key":"10.1016\/j.biopha.2017.05.095_bib0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00017.2013","article-title":"Targeting aldehyde dehydrogenase 2: new therapeutic opportunities","volume":"94","author":"Chen","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2017.05.095_bib0585","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1872213X11307020009","article-title":"Vitiligo and allergic complications from orthopaedic joint implants: the role of benzoyl peroxide","volume":"7","author":"Dudda","year":"2013","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"key":"10.1016\/j.biopha.2017.05.095_bib0590","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/archderm.144.3.310","article-title":"A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases","volume":"144","author":"Birlea","year":"2008","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0595","doi-asserted-by":"crossref","first-page":"e2013063","DOI":"10.4084\/mjhid.2013.063","article-title":"Contribution of marital distance to community inbreeding, homozygosis, and reproductive wastage for recessively inherited genetic disorders in madhya pradesh, India","volume":"5","author":"Balgir","year":"2013","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.biopha.2017.05.095_bib0600","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/0929867323666160119094516","article-title":"Role of tyrosine isomers in acute and chronic diseases leading to oxidative stress \u2013 a review","volume":"23","author":"Moln\u00e1r","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2017.05.095_bib0605","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5021\/ad.2010.22.3.279","article-title":"Erythrocyte malondialdehyde and glutathione levels in vitiligo patients","volume":"22","author":"Shin","year":"2010","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.biopha.2017.05.095_bib0610","first-page":"21","article-title":"Vitiligo and glaucoma \u2013 an association or a coincidence? A pilot study","volume":"18","author":"Rogosi\u0107","year":"2010","journal-title":"Acta Dermatovenerol. Croat."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217317511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217317511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:41:38Z","timestamp":1772264498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217317511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":122,"alternative-id":["S0753332217317511"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.05.095","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A holistic review on the autoimmune disease vitiligo with emphasis on the causal factors","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.05.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}